GlassScriptPhysician profile
Sufyan M Binmahfooz
NPI 1558070607
$1,977.59
in general payments reported to CMS, 2019-2025
17 companies · $1,060 in 2025
The $1,060 reported for 2025 was more than what 87% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $111 · 2024: $806 · 2025: $1,060.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,909 · Education: $69.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,908.59 |
| Education | $69.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Viiv Healthcare Company | $423.20 | 2024-2025 | Apretude |
| Pfizer INC. | $302.18 | 2024-2025 | |
| Abbvie INC. | $298.62 | 2024-2025 | |
| Gilead Sciences, INC. | $245.03 | 2024-2025 | Yeztugo |
| Novo Nordisk INC | $153.77 | 2024-2025 | Ozempic, Rybelsus, Wegovy |
| Lilly USA, LLC | $126.74 | 2024-2025 | Mounjaro, Zepbound |
| Merck Sharp & Dohme LLC | $115.82 | 2024-2025 | Gardasil 9, Capvaxive, Gardasil |
| Seagen INC. | $86.53 | 2023 | Tukysa |
| Boston Scientific Corporation | $50.70 | 2025 | Bodyguardian |
| Sanofi Pasteur INC. | $30.87 | 2025 | |
| Exact Sciences Corporation | $26.24 | 2024 | Cologuard Collection Kit |
| Array Biopharma INC | $24.94 | 2023 | Mektovi, Xalkori, Lorbrena |
| E.R. Squibb & Sons, L.L.C. | $21.15 | 2024 | Eliquis |
| Phadia US INC. | $20.89 | 2025 | Immunocap |
| Vertical Pharmaceuticals, LLC | $18.48 | 2024 | Relexxii |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $17.32 | 2025 | Inspire |
| Medtronic, INC. | $15.11 | 2025 | Inceptiv |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sufyan Binmahfooz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.